molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide

C26H27N5O — CID 155744250

IUPACmolecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide
SMILESO=C(N[C@H]1CCN(c2ccc3c(cnn3-c3ccncc3)c2)[C@@H]1c1ccccc1)C1CC1.[H][H]
InChIInChI=1S/C26H25N5O.H2/c32-26(19-6-7-19)29-23-12-15-30(25(23)18-4-2-1-3-5-18)22-8-9-24-20(16-22)17-28-31(24)21-10-13-27-14-11-21;/h1-5,8-11,13-14,16-17,19,23,25H,6-7,12,15H2,(H,29,32);1H/t23-,25+;/m0./s1
InChIKeyDXWMQERQTLQZQG-LMIIKYDLSA-N
MW425.54 g/mol
LogP4.51
Rot. Bonds5

About molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide

molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide (PubChem CID 155744250) has the molecular formula C26H27N5O and a molecular weight of 425.54 g/mol. Its IUPAC name is molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide.

Molecular Properties

Compound Namemolecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide
PubChem CID155744250
Molecular FormulaC26H27N5O
Molecular Weight425.54 g/mol
Exact Mass425.22
IUPAC Namemolecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide
SMILESO=C(N[C@H]1CCN(c2ccc3c(cnn3-c3ccncc3)c2)[C@@H]1c1ccccc1)C1CC1.[H][H]
InChIInChI=1S/C26H25N5O.H2/c32-26(19-6-7-19)29-23-12-15-30(25(23)18-4-2-1-3-5-18)22-8-9-24-20(16-22)17-28-31(24)21-10-13-27-14-11-21;/h1-5,8-11,13-14,16-17,19,23,25H,6-7,12,15H2,(H,29,32);1H/t23-,25+;/m0./s1
InChIKeyDXWMQERQTLQZQG-LMIIKYDLSA-N
XLogP4.51
TPSA63.05 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500425.54
LogP ≤ 54.51
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide?
The IUPAC name of molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide (CID 155744250) is molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide.
What is the SMILES notation for molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide?
The canonical SMILES for molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide is O=C(N[C@H]1CCN(c2ccc3c(cnn3-c3ccncc3)c2)[C@@H]1c1ccccc1)C1CC1.[H][H].
What is the InChIKey of molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide?
The InChIKey is DXWMQERQTLQZQG-LMIIKYDLSA-N. The full InChI is InChI=1S/C26H25N5O.H2/c32-26(19-6-7-19)29-23-12-15-30(25(23)18-4-2-1-3-5-18)22-8-9-24-20(16-22)17-28-31(24)21-10-13-27-14-11-21;/h1-5,8-11,13-14,16-17,19,23,25H,6-7,12,15H2,(H,29,32);1H/t23-,25+;/m0./s1.
What are the key properties of molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide?
molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide has a molecular weight of 425.54 g/mol, XLogP of 4.51, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for molecular hydrogen;N-[(2R,3S)-2-phenyl-1-(1-pyridin-4-ylindazol-5-yl)pyrrolidin-3-yl]cyclopropanecarboxamide is sourced from PubChem (CID 155744250), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).